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Williamsia muralis
Pulmonary
Infection 
To the Editor: Bacteria of the
genus  Williamsia are mycolic
acid–containing actinomycetes of the
suborder Corynebacterineae (1). This
suborder also includes the genera
Gordonia, Mycobacterium, Nocardia,
Corynebacterium,  Rhodococcus,
Dietzia,  Skermania,  Tsukamurella,
and Turicella (2,3). Within the genus
Williamsia, only 2 species have been
reported: Williamsia muralis, isolated
from a daycare center (4), and W.
maris, isolated from the Sea of Japan
(5). One important aspect shared by
both species is their apparent lack of
pathogenicity, since they have been
isolated only from environmental
samples. 
An 80-year-old woman, whose
medical history included allergy to
penicillin and high blood pressure,
was admitted to the cardiothoracic
intensive care unit at Juan Canalejo
Hospital Complex in La Coruña,
Spain, because of a loss of conscious-
ness following an aortic valve
replacement. Physical examination
showed a systolic murmur and an
echocardiogram showed aortic steno-
sis. Transaortic peak pressure was 100
mm Hg, and the aortic valvular area
was 0.3 cm2.  A biologic valve pros-
thesis (Mitroflow 21, Sorin Group
Canada, Ltd., Burnaby, British
Columbia, Canada) was inserted
under the cardiopulmonary bypass. 
Forty-eight hours later, the patient
had paroxysmal atrial fibrillation and
a temperature of 39°C, with severe
hemodynamic and respiratory impair-
ment. She was intubated and intra-
venous drugs were administered.
Blood and urine cultures were
requested. Central venous pressure
lines were changed, and cultures were
obtained. Empiric treatment with lev-
ofloxacin, amikacin, and teicoplanin
was started for the patient. One of 2
blood cultures was positive for
Staphylococcus epidermidis, as were
cultures from femoral and jugular
venous lines. Although considered a
contaminant, we observed that S. epi-
dermidis was susceptible to empiric
antimicrobial drugs.
One week later, a chest radiograph
showed bilateral alveolar infiltrates
suggestive of pulmonary edema
(Figure). To rule out infection, bron-
choscopy and protected specimen
brush were conducted. An unidentified
gram-positive bacillus was cultured
from the brush sample. Urine cultures
were positive for Candida kefyr, but
the patient showed no evidence of can-
didemia. An echocardiogram showed
no evidence of infective endocarditis.
Since the patient’s condition did not
improve, levofloxacin was replaced
with imipenem, and treatment with
fluconazole was initiated. However,
the patient developed septic shock,
adult respiratory distress syndrome,
and oliguric acute renal failure, and
died of multiple organ failure.
On direct examination, a Gram
stain of the protected specimen brush
sample showed numerous gram-posi-
tive bacilli. After incubation for 48 h
in either an aerobic or capnophilic
atmosphere,  >1,000 CFU/mL were
observed on Columbia agar plates
containing 5% sheep blood (BD
Stacker Plates, BBL, Franklin Lakes,
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Figure. Chest radiograph of the patient showing bilateral alveolar infiltrates. Although pul-
monary edema was the initial diagnosis, an infectious cause should be considered and,
on the basis of sepsis, appropriate treatment initiated.LETTERS
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NJ, USA). These colonies were
round, slightly convex, white to pale
yellow, and 1–3 mm in diameter.
Microscopic examination showed
short gram-positive bacilli. A few
colonies of coagulase-negative
staphylococci were also isolated from
the clinical sample.
We attempted biochemical identi-
fication of the gram-positive bacilli,
but discordant results were obtained.
Test results of cultures after 24 and
48 h with a commercial assay
(apiCoryne, bioMérieux, Marcy
l’Etoile, France) identified the bacilli
as a Rhodococcus spp. (probability
>98.2%). However, negative results
by Kinyoun modified acid-fast stain-
ing and by the CAMP test, 2 features
characteristic of Rhodococcus equi,
aroused suspicion regarding the
unusual properties of this isolate.
Genomic DNA was isolated from
the bacilli and analyzed by poly-
merase chain reaction (PCR)–mediat-
ed amplification of 16S ribosomal
DNA, purification of PCR products,
and direct sequencing, as previously
reported (6). The 16S rRNA gene
sequence (1,438 bp) of the isolate
(500/04; GenBank accession no.
AY986734) showed 99% similarity
with W. muralis (4). Other noteworthy
similarity matches of the isolate were
with  W. maris (96%),  Gordonia sp.
(95%), Nocardia transvalensis (95%),
and Rhodococcus sp. (95%).
Antimicrobial drug susceptibility
patterns were determined by using a
commercial assay (Trek Diagnostic
Systems Ltd., East Grinstead, UK).
Since no interpretive criteria exist for
Williamsia  spp., those previously
reported for Nocardia spp. (7,8) were
used for estimating breakpoints.
Results showed the isolate was sus-
ceptible to amoxicillin-clavulanate,
cefotaxime, imipenem, ciprofloxacin,
tobramycin, gentamicin, and cotri-
moxazole and resistant to ampicillin
and erythromycin after incubation for
48 h in either air or a CO2 atmosphere
(GasPak CO2 Pouch Capnophilic
System, BD Biosciences, Sparks,
MD, USA). Isolates of the genus
Williamsia are currently recognized as
environmental microorganisms (4,5).
However, its potential as a pathogen
in clinical infections has not been
reported.
In summary, we report the isolation
of >1,000 CFU/mLof W. muralis from
a protected specimen brush sample of
an 80-year-old woman. The number of
colonies obtained, as well as features
of the source of the clinical sample
and the chest radiograph (clearly
pathologic) at the time the isolate was
obtained, strongly suggest that this
microorganism was associated with
lung infiltrates and poor prognosis,
resulting in the death of the patient.
The isolation of a few colonies of a
coagulase-negative staphylococci may
be considered irrelevant.
We also report the antimicrobial
drug susceptibility pattern of
Williamsia spp. Since no clinical find-
ings for this genus have been reported,
no clinical recommendations have
been made regarding empiric treatment
for infections with this microorganism.
This is the first report of this bacterium
as a potential human pathogen.
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